Table 2. Association of clinical indicators with 3-year overall survival of triple-negative breast cancer (TNBC) patients.
| Items | Number of cases (n) | Uni-variate analysis | Multi-variate analysis | ||||
| HR | 95% CI | P value | HR | 95% CI | P value | ||
| Age (years old) | |||||||
| ≤50 | 37 | ||||||
| >50 | 46 | 0.593 | 0.285-1.232 | 0.161 | 0.672 | 0.313-1.445 | 0.309 |
| Diameter of lesion (cm) | |||||||
| ≤5 | 62 | ||||||
| > 5 | 21 | 2.574 | 1.228-5.393 | 0.012* | 2.696 | 1.222-5.946 | 0.014* |
| Classification | |||||||
| IDC | 70 | ||||||
| Others | 13 | 1.227 | 0.468-3.218 | 0.677 | 2.354 | 0.795-6.973 | 0.122 |
| TNM grade | |||||||
| G1+G2 | 64 | ||||||
| G3 | 19 | 1.813 | 0.825-3.982 | 0.139 | 1.105 | 0.468-2.614 | 0.819 |
| Ki-67 | |||||||
| ≤14% | 40 | ||||||
| >14% | 43 | 3.218 | 1.423-7.279 | 0.005* | 3.095 | 1.281-7.477 | 0.012* |
| Relative level of hsa_circ_0000199 | |||||||
| Low | 40 | ||||||
| High | 43 | 3.783 | 1.614-8.868 | 0.002* | 2.91 | 1.008-8.401 | 0.048* |
HR: hazard ratio; CI: confidence interval; *: statistical significance.